Search Our Website:
Sep 28 2022
9:30 AM - 4:00 PM

On Wednesday, September 28, Buchanan Life Sciences will be holding its first-ever Product Portfolio Optimization Summit for in-house attorneys and corporate practitioners.

This will consist of a full day of in-person CLE programming designed for decision-makers of life sciences companies. With the impact on product portfolios at the forefront, topics will range from election year issues on the table, enhancing approval tactics, optimized strategies for product acquisition and divestiture, key antitrust issues in litigation, compliance and more. The summit will also include a solution-focused Diversity & Inclusion program on attracting and retaining diverse talent within the Life Sciences space.

Register to attend here

Agenda Topics Include:

  • Election Year Presentation: Issues Impacting Life Sciences Companies & Their Portfolios
  • Crossing the Approval Divide: Cohesive Strategies from Concept Through Reimbursement
  • Recruiting & Retaining Diverse Life Sciences Talent: Solutions that Work
  • Leveraging Your Pharmaceutical Product Portfolio: Driving M&A And Target Identification
  • Strategies for Mitigating Legal Risk When Taking Your Product Portfolio to Market
  • Product Portfolios and Antitrust: Practical Implications of Recent Litigation

NY/NJ: 7 total credits (6 General; 1 Diversity)
PA : 6 total credits (5 General; 1 Ethics)
CA: 6 total credits (5 General; 1 Diversity)
Other states available upon request.